1. |
Choo QL, Kuo G, Weiner AJ, et al. Isolation of a cDNA clone derived from a blood-borne non-A, non-B viral hepatitis genome [J]. Science, 1989; 244(4902): 359-362.
|
2. |
Sklan EH, Charuworn P, Pang PS, et al. Mechanisms of HCV survival in the host [J]. Nat Rev Gastroenterol Hepatol, 2009; 6(4): 217-227.
|
3. |
Lonardo A, Loria P, Adinolfi LE, et al. Hepatitis C and steatosis: a reappraisal [J]. J Viral Hepat, 2006; 13(2): 73-80.
|
4. |
中华医学会肝病学分会、中华医学会传染病与寄生虫病学分会. 丙型肝炎防治指南 [J]. 中华肝脏病杂志, 2004; 12(4): 194-198.
|
5. |
Rosenberg S. Recent advances in the molecular biology of hepatitis C virus [J]. J Mol Biol, 2001; 313(3): 451-464.
|
6. |
Castello G, Scala S, Palmieri G, et al. HCV-related hepatocellular carcinoma: From chronic inflammation to cancer [J]. Clin Immunol, 2010; 134(3): 237-250.
|
7. |
Zhu Z, Wilson AT, Gopalakrishna K, et al. Hepatitis C virus core protein enhances Telomerase activity in Huh7 cells [J]. J Med Virol, 2010; 82(2): 239-248.
|
8. |
Xu Z, Choi J, Yen TS, et al. Synthesis of a novel hepatitis C virus protein by ribosomal frameshift [J]. EMBO J, 2001; 20(14): 3840-3848.
|
9. |
Branch AD, Stump DD, Gutierrez JA, et al. The hepatitis C virus alternate reading frame (ARF) and its family of novel products: the alternate reading frame protein/F-protein, the double-frameshift protein, and others [J]. Semin Liver Dis, 2005; 25(1): 105-117.
|
10. |
Vassilaki N, Mavromara P. Two alternative translation mechanisms are responsible for the expression of the HCV ARFP/F/core+1 coding open reading frame [J]. J Biol Chem, 2003; 278(42): 40503-40513.
|
11. |
Boulant S, Becchi M, Penin F, et al. Unusual multiple recoding events leading to alternative forms of hepatitis C virus core protein from genotype 1b [J]. J Biol Chem, 2003; 278(46): 45785-45792.
|
12. |
Gao JH, He ZJ, Wang Q, et al. Low expression of S100P associated with paclitaxel resistance in ovarian cancer cell line [J]. Chin Med J (Engl), 2008; 121(16): 1563-1568.
|
13. |
Jiao J, Friedman SL, Aloman C. Hepatic fibrosis [J]. Curr Opin Gastroenterol, 2009; 25(3): 223-229.
|
14. |
Marra F, Aleffi S, Galastri S, et al. Mononuclear cells in liver fibrosis [J]. Semin Immunopathol, 2009; 31(3): 345-358.
|
15. |
Ghiassi-Nejad Z, Friedman SL. Advances in antifibrotic therapy [J]. Expert Rev Gastroenterol Hepatol, 2008; 2(6): 803-816.
|
16. |
Friedman SL. Hepatic stellate cells: protean, multifunctional, and enigmatic cells of the liver [J]. Physiol Rev, 2008; 88(1): 125-172.
|
17. |
Kordes C, Sawitza I, Hussinger D. Hepatic and pancreatic stellate cells in focus [J]. Biol Chem, 2009; 390(10): 1003-1012.
|
18. |
Svegliati-Baroni G, De Minicis S, Marzioni M. Hepatic fibrogenesis in response to chronic liver injury: novel insights on the role of cell-to-cell interaction and transition [J]. Liver Int, 2008; 28(8): 1052-1064.
|
19. |
Hatok J, Babusikova E, Matakova T, et al. In vitro assays for the evaluation of drug resistance in tumor cells [J]. Clin Exp Med, 2009; 9(1): 1-7.
|
20. |
刘颖, 梁惠, 苏爱, 等. 海兔素对人胃癌细胞SGC-7901增殖和凋亡的影响 [J]. 中国药理学通报, 2010; 26(3): 333-337.
|